Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.
Tansri WibowoShoji KawadaYutaka IshidaYuko YoshimineNachi IshikawaKeisuke KawamotoYasuhiro KatoShinji HigaAtsushi OgataKeiji MaedaPublished in: Modern rheumatology case reports (2019)
A 66-year-old woman presented with severe anaemia, thrombocytopenia and lymphopenia. The bone marrow biopsy demonstrated hypocellular marrow with myelofibrosis (MF); there was no evidence of malignancy, but infiltration of peripheral T and B cells were noticed. Magnetic resonance imaging (MRI) revealed that bone marrow of the spine exhibited low signal intensity (SI) with spotty high SI in T1- and T2-weighted images. Because there was evidence of autoimmune abnormality, she had fulfilled the classification criteria for systemic lupus erythematosus (SLE). She was diagnosed with autoimmune myelofibrosis (AIMF) associated with SLE and was treated with corticosteroid. Cytopenia improved after 1 month of corticosteroid therapy. A repeated bone marrow biopsy demonstrated that cellularity had increased and that the amount of reticulin fibre had reduced after treatment. Compared with primary MF, AIMF has generally a favourable prognosis and is often associated with autoimmune diseases, especially SLE. Bone marrow biopsy, but not aspiration, was useful for diagnosing bone marrow fibrosis. Although the association between SLE and MF has been rarely reported, we should pay attention to MF as a possible cause of pancytopenia.
Keyphrases
- systemic lupus erythematosus
- bone marrow
- disease activity
- mesenchymal stem cells
- magnetic resonance imaging
- ultrasound guided
- multiple sclerosis
- contrast enhanced
- drug induced
- machine learning
- magnetic resonance
- computed tomography
- rheumatoid arthritis
- stem cells
- room temperature
- working memory
- optical coherence tomography
- high intensity
- health insurance
- diffusion weighted imaging
- ionic liquid